CDXS Share Price

Open 4.75 Change Price %
High 4.90 1 Day 0.05 1.04
Low 4.70 1 Week 0.20 4.30
Close 4.85 1 Month 0.30 6.59
Volume 68330 1 Year 0.95 24.36
52 Week High 5.25
52 Week Low 0.00
CDXS Important Levels
Resistance 2 5.04
Resistance 1 4.96
Pivot 4.82
Support 1 4.74
Support 2 4.66
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
QKLS 0.12 -36.84%

Codexis, Inc. (NASDAQ: CDXS)

CDXS Technical Analysis 4
As on 7th Dec 2016 CDXS Share Price closed @ 4.85 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.05 & Buy for SHORT-TERM with Stoploss of 4.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
CDXS Target for December
1st Target up-side 5.19
2nd Target up-side 5.49
3rd Target up-side 5.8
1st Target down-side 4.31
2nd Target down-side 4.01
3rd Target down-side 3.7
CDXS Other Details
Segment EQ
Market Capital 100055984.00
Sector Healthcare
Industry Biotechnology
Offical website
CDXS Address
200 Penobscot Drive
Redwood City, CA 94063
United States
Phone: 650-421-8100
CDXS Latest News
Trading Views: RSI, MA, and ADX Review for Codexis Inc. (CDXS)   Yankee Analysts   - 07th Dec 16
Codexis to Commercially Supply Proprietary Enzyme to Tate & Lyle   GlobeNewswire (press release)   - 06th Dec 16
Stock Watch on Shares of Codexis, Inc. (NASDAQ:CDXS)   Liberty News   - 05th Dec 16
Despite Recent Market Upturn, This Stock Struggled This Week: Codexis, Inc ...   CSZ News   - 04th Dec 16
Codexis (CDXS) Appoints New Board Chair   - 01st Dec 16
Stock Returns: Codexis Inc (NASDAQ:CDXS) versus Rayonier Advanced Materials ...   CML News   - 30th Nov 16
Patrick Y. Yang Acquires 10000 Shares of Codexis Inc. (CDXS) Stock   The Cerbat Gem   - 16th Nov 16
Codexis Inc. (CDXS) Director Purchases $48300.00 in Stock   BBNS   - 16th Nov 16
Can Codexis Maintain Its Clout?   Seeking Alpha   - 06th May 16
Codexis Inc.   MarketWatch   - 22nd Apr 10
Interactive Technical Analysis Chart Codexis, Inc. ( CDXS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Codexis, Inc.
CDXS Business Profile
Codexis, Inc., incorporated in January 2002, is a producer of custom industrial enzymes. The Company's products enable processes for the manufacture of biofuels, bio-based chemicals and pharmaceutical ingredients. As of December 31, 2011, the Company was developing its CodeXyme cellulase enzymes to convert non-food plant material, which the Company calls cellulosic biomass, into sugars, which can then be converted into renewable fuels and chemicals. The Company intends to market CodeXyme cellulase enzymes to chemicals manufacturers worldwide. The Company is also developing its own manufacturing processes for certain specialty and commodity bio-based chemicals. The first of these products is CodeXol detergent alcohols. Detergent alcohols are used to manufacture surfactants, which are key, active cleaning ingredients in consumer products, such as shampoos, liquid soaps and laundry detergents. The Company has commercialized its technology, products and services in the pharmaceuticals market. As of December 31, 2011, there were over 50 pharmaceutical firms using the Company's technology, products and services in their manufacturing process development. The Company creates its products by applying its CodeEvolver directed evolution technology platform, which introduces genetic mutations into microorganisms, giving rise to changes in the enzymes which they produce. CodeXyme cellulase enzymes function by transforming cellulosic biomass into sugars, a process known as saccharification. The resulting sugars from saccharification can be converted into fuels and chemicals through fermentation. The Company is also developing microorganisms that produce chemicals from cellulosic sugars. These microorganisms function as mini fermentation factories that convert sugars into specialty or commodity chemicals. As of December 31, 2011, the Company was developing its fully integrated cellulosic CodeXol detergent alcohols manufacturing process, from feedstock to product, in collaboration with Chemtex. The Company markets and sells enzymes, development services and screening tools that enables manufacturing processes for active pharmaceutical ingredients (APIs) and their precursor pharmaceutical intermediates. The Company also markets and sells pharmaceutical intermediates that are manufactured using its custom enzymes. The Company sells its products and services to both the generic and on-patent pharmaceutical ends markets. CodeXol detergent alcohols are manufactured using a process, which is amenable to various types of cellulosic biomass, including sugarcane bagasse, wheat straw, corn stover and various energy crops, such as Arundo donax.